Replay available

GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call

GE HealthCare Technologies Inc. (NASDAQ: GEHC) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Wed, October 29, 2025 at 8:30 AMendedReplay
GE HealthCare Technologies Inc. (GEHC) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Caroline Borders

Investor Relations Officer

Peter Arduini

President and CEO

Jay Saccaro

Vice President and CFO

Lawrence Bigelson

Analyst, Wells Fargo Securities

Travis Seed

Analyst, Bank of America Securities

Joan Wensch

Analyst, Citibank

David Roman

Analyst, Goldman Sachs

Patrick Wood

Analyst, Morgan Stanley

Vijay Kumar

Analyst, Evercore ISI

Matt McSick

Analyst, Barclays

Robert Marcus

Analyst, JP Morgan

Anthony Petrone

Analyst, Mizuho Americas

Replay transcript excerpt

everyone and welcome to GE Healthcare third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To participate, you will need to press star 1 1 on your telephone. You will then hear a message advising your hand is raised. To withdraw your question, simply press star 1 1 again. Please note that this conference is being recorded. Now it's my pleasure to turn the call over to the Investor Relations Officer, Caroline Borders. Please proceed. Thanks, Operator. Good morning and welcome to GE Healthcare's third quarter 2025 earnings call. I'm joined by our President and CEO, Peter Arduini, and Vice President and CFO, Jay Saccaro. Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website. During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties. With that, I'll hand the call over to Peter. Thanks, Carolyn. Good morning, and thank you for joining us today. We delivered another quarter of solid results and were focused on executing our precision care strategy. In the third quarter, organic revenue grew 4%. We delivered robust orders growth of 6% with growth across all segments. This reflects solid customer demand for our innovative solutions, a healthy capital equipment environment, and our strong commercial execution. We're now entering a new wave of innovation as a result of our increased R&D investments over th...

More from Ge Healthcare Technologies Inc.